Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $4.93 in the prior trading day, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $4.54, down -8.00%. In other words, the price has decreased by -$8.00 from its previous closing price. On the day, 2.29 million shares were traded. MRVI stock price reached its highest trading level at $5.02 during the session, while it also had its lowest trading level at $4.51.
Ratios:
Our goal is to gain a better understanding of MRVI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.
On December 05, 2024, Goldman Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $4.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeFord John A bought 17,500 shares for $5.75 per share. The transaction valued at 100,625 led to the insider holds 70,046 shares of the business.
HULL CARL bought 175,000 shares of MRVI for $987,000 on Nov 11 ’24. The insider now owns 175,000 shares after completing the transaction at $5.64 per share. On May 28 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 9,940,974 shares for $9.81 each. As a result, the insider received 97,570,660 and left with 20,150,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1146477056 and an Enterprise Value of 947142528. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.14 while its Price-to-Book (P/B) ratio in mrq is 1.86. Its current Enterprise Value per Revenue stands at 3.42 whereas that against EBITDA is 914.23.
Stock Price History:
The Beta on a monthly basis for MRVI is -0.06, which has changed by -0.20659167 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is -20.05%, while the 200-Day Moving Average is calculated to be -41.84%.
Shares Statistics:
The stock has traded on average 1.94M shares per day over the past 3-months and 1948270 shares per day over the last 10 days, according to various share statistics. A total of 141.59M shares are outstanding, with a floating share count of 117.45M. Insiders hold about 17.20% of the company’s shares, while institutions hold 89.83% stake in the company. Shares short for MRVI as of 1735603200 were 8507989 with a Short Ratio of 4.38, compared to 1732838400 on 7904243. Therefore, it implies a Short% of Shares Outstanding of 8507989 and a Short% of Float of 7.1499999999999995.
